
20% Less Dementia with Shingles Vaccine
Stanford Medicine’s new analysis of a vaccination program found shingles vaccines appear to lower dementia diagnoses by 20% — more than any other known intervention.
Stanford Medicine’s new analysis of a vaccination program found shingles vaccines appear to lower dementia diagnoses by 20% — more than any other known intervention.
In an Alzheimer’s study, insulin delivered high up in the nasal cavity achieved lasting results in improving memory. Find out why Dr. W. Banks calls this “one of those studies where everything is coming together.”
Three FDA-Approved drugs, terazosin, doxazosin, and alfuzosin, have a happy side effect; they boost energy production in brain cells. New studies suggest this slows or prevents Dementia with Lewy Bodies.
People with Parkinson’s were given the oral drug rivastigmine (brand name Exelon®). They were 45% less likely to fall and were considerably steadier when walking. Learn more about this dementia drug and fall prevention.
DRUGS: Long-term antibiotic treatment decreased Alzheimer’s-causing plaques in the lab. It also helped the brain fight inflammation by enhancing the neuroinflammatory activity of microglial cells.
GOOD NEWS: Donepezil (Aricept®), approved for Alzheimer’s, also passed a long-term trial for Dementia with Lewy Bodies (DLB). Get the details on the medicine’s positive
OFF-LABEL MEDICATIONS: Memantine (Namenda / Ebixa) is FDA-approved for Alzheimer’s. Learn how it significantly improves memory and attention in Lewy Body Disease, Parkinson’s and various
OFF-LABEL: An approved prescription drug for high blood pressure is showing promise against Parkinson’s, Huntington’s and other forms of dementia, in experimental studies in the
126 DRUGS ARE IN ALZHEIMER’S clinical trials. “Every single one represents hope,” according to Closing in on a Cure: Alzheimer’s Clinical Trials Report. Read the
In the lab, fujimycin slowed Alzheimer’s. (Fujimycin is an organ-transplant drug also called FK506 or Tacrolimus.) In past studies, similar drugs, like rapamycin and ciclosporin,
Selling Alzheimer’s books takes time – buyers rarely commit right away. Smart authors plan for the long game, offering gentle, repeated reminders to buy. No tool does this more effectively or simply than the Alzheimer’s & Dementia Weekly Newsletter service. Keep your book—and its message—at the center of your readers’ attention.
SHORT-TERM MEMORY lapses are obvious signs of Alzheimer’s, but other tell-tale signals begin to show much earlier. Learn how to look for semantic impairments, such as simple questions about size.
Discover compassionate, practical and proven strategies to navigate dementia care confidently, ensuring the well-being of both you and your loved one.
SHORT-TERM MEMORY lapses are obvious signs of Alzheimer’s, but other tell-tale signals begin to show much earlier. Learn how to look for semantic impairments, such as simple questions about size.
Three important dementia studies focus on HS-AGING, a type of dementia almost as common as Alzheimer’s in the 85+ group. Yet few people have heard of it. Why? What makes it different?
An intriguing study of 120 grandmothers might surprise you. Doctors know socially engaged people have better cognition and less dementia. But can a person get too much of a good thing? What’s the right balance?
Enjoy this great duet between a musician with dementia and his son. A triumph of spirit over Alzheimer’s! Sing-a-long if you like!
No spam, only news and updates.